Elliott B. Grossbard
2012
In 2012, Elliott B. Grossbard earned a total compensation of $1.6M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $239,262 |
|---|---|
| Option Awards | $827,130 |
| Salary | $503,709 |
| Other | $5,148 |
| Total | $1,575,249 |
Grossbard received $827.1K in option awards, accounting for 53% of the total pay in 2012.
Grossbard also received $239.3K in non-equity incentive plan, $503.7K in salary and $5.1K in other compensation.
Rankings
In 2012, Elliott B. Grossbard's compensation ranked 4,390th out of 11,487 executives tracked by ExecPay. In other words, Grossbard earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,390 out of 11,487 | 62nd |
Division Manufacturing | 1,521 out of 4,253 | 64th |
Major group Chemicals And Allied Products | 347 out of 1,203 | 71st |
Industry group Drugs | 214 out of 925 | 77th |
Industry Pharmaceutical Preparations | 165 out of 700 | 76th |
Source: SEC filing on March 30, 2015.
Grossbard's colleagues
We found four more compensation records of executives who worked with Elliott B. Grossbard at Rigel Pharmaceuticals in 2012.